Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart.

Grossman AN, Opie LH, Beshansky JR, Ingwall JS, Rackley CE, Selker HP.

Circulation. 2013 Mar 5;127(9):1040-8. doi: 10.1161/CIRCULATIONAHA.112.130625. Review. No abstract available.

2.

[Metabolic therapy with glucose-insulin-potassium. Historical outline].

de Micheli A.

Arch Inst Cardiol Mex. 2000 Nov-Dec;70(6):609-15. Spanish. No abstract available.

PMID:
11255721
3.
5.

[Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments in favor].

Alegría Ezquerra E, Maceria González A.

Rev Esp Cardiol. 1998 Sep;51(9):720-6. Review. Spanish.

6.

[Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].

Dainese L, Polvani GL, Fumero A, Spirito R, Alamanni F, Agrifoglio M, Parolari A, Biglioli P.

G Ital Cardiol. 1999 May;29(5):575-9; discussion 580-2. Review. Italian. No abstract available.

PMID:
10367228
7.

Metabolic modulation of acute myocardial infarction.

Diaz R.

Crit Care Clin. 2001 Apr;17(2):469-76. Review.

PMID:
11450327
8.

Management of blood glucose in patients with acute coronary syndromes.

Lipska KJ, Kosiborod M.

Rev Cardiovasc Med. 2012;13(2-3):e77-88. Review.

PMID:
23160165
9.

A new look at an old therapy.

Califf RM.

JAMA. 2012 May 9;307(18):1972-3. doi: 10.1001/jama.2012.4434. No abstract available.

PMID:
22570466
10.
11.

Glycometabolic status and acute myocardial infarction: has the time come for glucose-insulin-(potassium) therapy?

Wong V, Cheung NW, Boyages SC.

Intern Med J. 2003 Sep-Oct;33(9-10):443-9. Review.

PMID:
14511197
12.

[On metabolic therapeutics G-I-K in surgery of cardiac patients].

de Micheli A, Medrano GA.

Arch Cardiol Mex. 2004 Jul-Sep;74(3):215-9. Review. Spanish.

PMID:
15559874
13.

Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".

Doenst T, Amorim PA.

Scand Cardiovasc J. 2010 Feb;44(1):4-8. doi: 10.3109/14017430903469928. No abstract available.

PMID:
20141343
14.
15.

Metabolic modulation for cardiac protection.

Weinberg GL, Massad MG.

Expert Rev Cardiovasc Ther. 2007 Mar;5(2):135-8. No abstract available.

PMID:
17338658
16.

Metabolic intervention for the ischemic and post-ischemic heart.

Svedjeholm R, Håkanson E, Szabó Z.

Wien Klin Wochenschr. 1999 Jul 9;111(13):501-11. Review.

PMID:
10444803
17.

Glucose, insulin, and the cardiovascular system.

Broomhead CJ, Colvin MP.

Heart. 2001 May;85(5):495-6. No abstract available.

18.

Limiting ischemic myocardial damage using glucose-insulin-potassium solutions.

Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ.

Ann Thorac Surg. 1995 Aug;60(2):411-6.

PMID:
7646105
19.

Glucose/insulin/potassium therapy: a reevaluation of myocardial benefits during cardiopulmonary bypass.

Wiese S, Askanazi J.

J Cardiothorac Vasc Anesth. 1992 Oct;6(5):517-20. No abstract available.

PMID:
1421062
20.

Myocardial metabolism during infusion of glucose-insulin-potassium before coronary artery bypass grafting.

Zwölfer W, Hiesmayr M, Andorfer M, Coraim F, Haslinger B, Holzinger C, Perger P, Mouhieddine M, Müller C, Rosenits C, et al.

J Cardiothorac Anesth. 1989 Oct;3(5 Suppl 1):46. No abstract available.

PMID:
2520984
Items per page

Supplemental Content

Support Center